Matthew's practice focuses on corporate and securities law. Matthew advises issuers, investors and dealers in public and private corporate finance transactions such as venture capital financings, private placements and public offerings including IPOs. Matthew also advises acquirers and targets undertaking various types of public and private M&A transactions including share acquisitions, plans of arrangement and other business combinations. Matthew’s practice has also included advising clients in corporate reorganization and conversion transactions. In addition to his transactional practice, Matthew has been involved in representing a number of emerging biotech and medical device companies in various corporate matters and transactions, including private placements and licensing transactions. Matthew provides ongoing advice on Canadian corporate and securities laws to clients ranging from established public issuers to technology start-ups.